WELL Health Technologies (TSE:WELL) Releases Quarterly Earnings Results

WELL Health Technologies (TSE:WELL) posted its quarterly earnings results on Monday. The company reported C$0.11 earnings per share (EPS) for the quarter, FiscalAI reports. WELL Health Technologies had a return on equity of 0.44% and a net margin of 0.25%. The firm had revenue of C$407.40 million during the quarter.

Here are the key takeaways from WELL Health Technologies’ conference call:

• Canadian Clinics reached a CAD 100 million annualized adjusted EBITDA run rate one quarter ahead of schedule. Q3 revenue grew 49%, adjusted EBITDA rose 82%, and same-clinic sales increased 12%, with management citing stronger margins and productivity.
• On a normalized basis, Q3 revenue increased 17% to CAD 407.4 million and adjusted EBITDA rose 20% to CAD 50.9 million, as growth shifted toward higher-margin businesses. Comparisons exclude CAD 17.6 million of Circle Medical revenue deferrals in the prior-year quarter.
• WELL updated 2026 revenue guidance to approximately CAD 1.58 billion, citing acquisition timing, slower second-half M&A, and weakness in U.S. provider staffing. It maintained adjusted EBITDA guidance of CAD 185 million to CAD 195 million.
• The WELLSTAR listing converted about CAD 155 million of preferred-share liabilities into equity, while a CAD 150 million bond offering helped repay convertible debentures and extend maturities to 2031, improving balance-sheet flexibility.
• WELL reported a CAD 135.5 million net loss, including CAD 67.5 million of non-cash impairments and WELLSTAR transaction-related charges; adjusted free cash flow attributable to shareholders was CAD 13.3 million, down from CAD 15.1 million. Management said two of three U.S. asset-sale processes had advanced with focused counterparties, but no binding outcomes were announced.

WELL Health Technologies Stock Performance

Shares of WELL stock opened at C$4.25 on Tuesday. The company has a quick ratio of 1.02, a current ratio of 0.80 and a debt-to-equity ratio of 100.05. The company has a 50 day moving average price of C$4.24 and a 200-day moving average price of C$4.19. WELL Health Technologies has a 52 week low of C$3.58 and a 52 week high of C$5.19. The firm has a market capitalization of C$1.09 billion, a PE ratio of 212.50, a P/E/G ratio of -1.93 and a beta of 0.51.

Wall Street Analysts Forecast Growth

Separately, TD set a C$8.50 target price on shares of WELL Health Technologies and gave the stock a “buy” rating in a report on Monday, October 5th. Five research analysts have rated the stock with a Buy rating. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of C$7.40.

About WELL Health Technologies

WELL Health Technologies Corp. (TSX: WELL) is Canada’s largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services.